September 15, 2026 · Menopause (New York, N.Y.) · DOI: 10.1097/GME.0000000000002880

Nonsedating neurotransmitter-modulating supplement for nonvasomotor sleep disturbance in menopause

Listen to this summary

The authors aimed to evaluate the efficacy of a neurotransmitter-modulating supplement in improving sleep quality among perimenopausal and postmenopausal women experiencing nonvasomotor sleep disturbances. The study found that the supplement significantly enhanced sleep quality, increased total sleep time, and improved sleep-related impairment compared to a placebo, with no notable differences in adverse events between groups.

Stephen Carbonneau, Vincent Mysliwiec, Audra Lisa Doyle, Matthew Stratton, Alyssa Dweck, Jaime Tartar, Michaela Alesi, Laura Mason, James Komorowski, Trisha A VanDusseldorp

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play